Press Releases

The global nanotechnology in the medical devices market is expected to witness a CAGR of 36.3% during the forecast period 2025-30. Factors attributing to the growth of nanotechnology in the medical devices market include the initiatives by the government to support technology development in nanotechnology like nanotech in contact lenses and VR, nanotech detectors for heart attack, mini 3D printed batteries for biosensors, etc. will accelerate the growth in the market. Moreover, the rising geriatric population, and their age-related diseases, increasing optimism for nanotechnology in the medicinal field to bring significant development in the diagnosis treatment and to prevent various diseases will augment the growth of nanotechnology in the medical device industry. 

Stryker has acquired HyperBranch Medical Technology, Inc., to enhance its cranial closure portfolio and strengthen its position in the neurotechnology business.

The COVID-19 pandemic has affected nanotechnology in the medical devices industry significantly but medical device supplying and life-saving products are not affected by the coronavirus. A new nano-vaccine metastasis platform has been established for COVID-19 therapeutics and vaccines to Coronavirus in patients.

Browse 41 market data Tables and 30 Figures spread through 200 Pages and in-depth TOC on " Nanotechnology-Based Medical Devices Market by Product (Active Implantable Devices, Medical Textiles, and Wound Dressings, Biochips, Implantable Materials, and Others), and by Application (Therapeutic Applications, Research Applications, and Diagnostic Applications), and Region - Global Forecast to 2030"

By product, the active implantable devices segment contributes to the largest share in the nanotechnology-based medical devices market.

Based on product, the active implantable devices segment dominates the market owing to growth-related disorders and includes hearing disorders, and cardiovascular ailments, and increasing incidence of lifestyle-associated diseases. Moreover, the presence of well-established channels of distribution, growing healthcare spending, and accessibility of several reimbursements and insurance coverage will drive the growth of nanotechnology in the medical devices market.

Global Nanotechnology-Based Medical Devices Market Segmentation and Key Players

Discover More About This Report, Download A Free Sample Copy of Nanotechnology-Based Medical Devices Market

“Asia-Pacific is projected to witness the fastest growing region during 2025-2030.”

Asia-Pacific is anticipated to be the fastest-growing region owing to the increasing elderly population, mounting international research collaborations, increased nanotechnology R&D spending, and robust growth of the healthcare industry in the region will fuel the growth of nanotechnology in medical devices industry.

Some of the major players in the global nanotechnology-based medical devices market include 3M Company, AAP Implantate AG, Smith & Nephew PLC, Dentsply Sirona Inc., Perkinelmer, Inc., Stryker Corporation, Mitsui Chemicals, Inc., and Starkey Hearing Technologies.

Global Nanotechnology-Based Medical Devices Market Coverage

Product Insight and Forecast 2025-2030

• Active Implantable Devices
• Medical Textiles, and Wound Dressings
• Biochips
• Implantable Materials
• Others

Application Insight and Forecast 2025-2030

• Therapeutic Applications
• Research Applications
• Diagnostic Applications

Geographical Segmentation

Nanotechnology-Based Medical Devices Market by Region

North America

• By Product
• By Application
• By Country – U.S., Canada, and Mexico

Europe

• By Product
• By Application
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Product
• By Application
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Product
• By Application
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries